HOOKIPA Pharma Ownership | Who Owns HOOKIPA Pharma?
HOOKIPA Pharma Ownership Summary
HOOKIPA Pharma is owned by 6.91% institutional investors, 1.98% insiders, and 91.12% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 6.48% of HOOK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.87% of its assets in HOOKIPA Pharma shares.
HOOK Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | HOOKIPA Pharma | 6.91% | 1.98% | 91.12% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Baker bros. advisors lp | 812.81K | 6.48% | $877.84K |
Ikarian capital | 53.00K | 0.42% | $57.24K |
Engineers gate manager lp | - | - | - |
Truvestments capital | - | - | - |
Millennium management | - | - | - |
Parallel advisors | - | - | - |
Hrt financial lp | - | - | - |
Citigroup | - | - | - |
Redmile group | - | - | - |
Ecor1 capital | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Baker bros. advisors lp | 812.81K | 0.01% | $877.84K |
Ikarian capital | 53.00K | 0.01% | $57.24K |
Engineers gate manager lp | - | - | - |
Truvestments capital | - | - | - |
Millennium management | - | - | - |
Parallel advisors | - | - | - |
Hrt financial lp | - | - | - |
Citigroup | - | - | - |
Redmile group | - | - | - |
Ecor1 capital | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baker bros. advisors lp | 812.81K | 0.01% | - |
Ikarian capital | 53.00K | 0.01% | - |
Truvestments capital | - | - | -2.00 |
Citigroup | - | - | -7.00 |
Parallel advisors | - | - | -35.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -388.86K |
Redmile group | - | - | -106.38K |
Engineers gate manager lp | - | - | -23.71K |
Millennium management | - | - | -15.33K |
Hrt financial lp | - | - | -11.31K |
Sold Out
Holder | Change |
---|---|
Truvestments capital | -2.00 |
Citigroup | -7.00 |
Parallel advisors | -35.00 |
Hrt financial lp | -11.31K |
Millennium management | -15.33K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 2 | -94.74% | 865,810 | -83.76% | 6 | 0.38% | - | -100.00% | - | -100.00% |
Dec 31, 2024 | 1 | - | 498,625 | -9.63% | 3 | 20.54% | - | - | 1 | - |
Sep 30, 2024 | 1 | -97.62% | 551,738 | -97.97% | 4 | 0.94% | - | -100.00% | 1 | -85.71% |
Jun 30, 2024 | 42 | -16.00% | 27,116,470 | -24.40% | 21 | 1.50% | 22 | 4.76% | 7 | 16.67% |
Mar 31, 2024 | 50 | 25.00% | 35,866,652 | 2.83% | 37 | 2.20% | 21 | 50.00% | 6 | -45.45% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 228.38K | 1.87% | - |
Vanguard US Total Market Shares ETF | 140.79K | 1.17% | - |
Fidelity VIP Growth Initial | 101.45K | 0.84% | - |
Fidelity Capital Appreciation | 91.62K | 0.76% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 69.84K | 0.57% | - |
Fidelity Advisor Equity Growth I | 66.86K | 0.55% | - |
Fidelity Growth Discovery | 45.08K | 0.37% | - |
Fidelity Extended Market Index | 39.45K | 0.33% | 2.26K |
Dimensional US Core Equity 2 ETF | 23.95K | 0.20% | - |
PGIM Quantitative Solutions US Micro Cap | 14.40K | 0.12% | 8.70K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 21, 2023 | Kandera Reinhard | Chief Financial Officer | Buy | $5.08K |
Aug 16, 2023 | Kandera Reinhard | Chief Financial Officer | Buy | $5.71K |
Jul 11, 2023 | Aldag Jorn | Chief Executive Officer | Buy | $4.14K |
Jul 07, 2023 | Aldag Jorn | Chief Executive Officer | Buy | $4.05K |
Jul 05, 2023 | Aldag Jorn | Chief Executive Officer | Buy | $4.45K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | - |
2024 Q2 | - | - |
2023 Q4 | - | - |
2023 Q3 | 6 | - |
2023 Q2 | 1 | - |
HOOK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools